Cases & Deals

Kaye Enterprises and Solon Ventures invest in Peakdale Molecular

Clients Kaye Enterprises Limited and Solon Ventures Limited

Jones Day represented Kaye Enterprises Limited and Solon Ventures Limited in connection with their purchase of Ordinary Shares and A Ordinary Shares in a private placement by Peakdale Molecular Limited, a provider of chemical products and services to pharmaceutical and biotechnology companies to accelerate drug discovery initiatives, in a second round investment.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.